Phase 3 Liver Cancer Trial, Recruiting NCT02885753 Sponsor: Federation Francophone de Cancerologie Digestive Condition: Liver Cancer
Back to Liver Cancer

Phase 3 Liver Cancer Trial, Recruiting

NCT02885753
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with colorectal cancer (bowel cancer) that has spread to the liver, confirmed by a tissue sample (biopsy)
  • You have at least one liver tumour that can be measured using standard scanning methods
  • Your cancer has only spread to the liver, or if it has also spread to the lungs, there are no more than 3 lung spots and each one is smaller than 10mm
  • Your tumour has been tested to find out whether it has specific gene changes (called RAS, KRAS, and NRAS mutations)
  • You are 18 years old or older
  • You are reasonably well and able to carry out daily activities (confirm with trial site regarding exact fitness level required)
  • You have not had chemotherapy before, unless it was given around the time of surgery and finished more than 12 months ago
  • Your doctors expect you to live for more than 3 months
  • Your blood counts (white blood cells, platelets, and haemoglobin) are above certain minimum levels (confirm with trial site)
  • Your liver and kidney function blood test results are within acceptable ranges (confirm with trial site)
  • Your kidney function meets a minimum level measured by a specific calculation
  • You are registered with a social security scheme (this appears to be a French healthcare requirement)
  • You have been fully informed about the trial and have signed a consent form

Who may not be able to join:

  • You have a blockage or unusual blood vessel structure in the liver artery that could affect a specific procedure or future surgery (confirm with trial site)
  • Your doctors have already decided you are suitable for surgery or a procedure aimed at curing your cancer right now
  • You have had a heart attack, chest pain, heart bypass surgery, significant heart failure, stroke, or mini-stroke in the past 6 months
  • Your blood pressure is too high and cannot be controlled with medication
  • You have had a hole or tear in your gut, an abscess in your abdomen, or significant gut bleeding in the past 6 months
  • You currently have an active stomach or duodenal ulcer, an unhealed wound, or a broken bone that has not yet healed
  • You have had major surgery or radiotherapy in the 4 weeks before starting the trial
  • You have had an organ transplant, are HIV positive, or have another condition that affects your immune system
  • You have had serious, ongoing liver, kidney, or breathing problems in the past 6 months that are not well controlled
  • You have significant nerve damage in your hands or feet (peripheral neuropathy above a mild level)
  • You have a lung condition called interstitial pneumonitis or pulmonary fibrosis
  • You have a history of severe chronic diarrhoea, inflammatory bowel disease, or a current blockage in your bowel
  • You have had another cancer in the past 5 years, unless it was a certain type of treated skin cancer or early-stage cervical cancer now in full remission
  • You are already taking part in another clinical trial involving an experimental treatment
  • You have a known allergy or serious reaction to any of the medicines used in this trial
  • You have a known deficiency of an enzyme called DPD (which affects how certain chemotherapy drugs are processed by the body)
  • Your heart's electrical activity (measured by an ECG) shows a reading that is too high (above 450 milliseconds for men or 470 milliseconds for women)
  • Your blood levels of potassium, magnesium, or calcium are below the normal range
  • You are pregnant, breastfeeding, or of childbearing age and not using effective contraception, or have not had a pregnancy test when required
  • You are currently under legal supervision or have restrictions on your freedom
  • It would not be possible for you to attend regular medical check-ups during the trial due to where you live, your personal situation, or other reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Julien TAIEB, MD-PhD, HEGP, Paris

Phone: +33 (0)380393404

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Federation Francophone de Cancerologie Digestive
Registry
ClinicalTrials.gov
Start date
1 December 2016
Est. completion
1 September 2028

Where this trial is recruiting

🇧🇪 Belgium 🇫🇷 France

Primary endpoints

progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov